Tulane University School of Medicine is a clinical research site located in New Orleans, Louisiana, United States 70112-2600.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Tulane University School of Medicine has participated in 243 clinical trials with 57 currently active.
Therapeutic areas: Castrate-Resistant Prostate Cancer, COVID, Chronic Lymphocytic Leukemia.
Sponsors: Hoffmann-La Roche, Kiniksa Pharmaceuticals International, plc, National Cancer Institute (NCI).
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tulane University School of Medicine has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tulane University School of Medicine has 243 clinical trials on record, with 57 currently active. Their work covers Castrate-Resistant Prostate Cancer, COVID, Chronic Lymphocytic Leukemia.
Tulane University School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.